674 related articles for article (PubMed ID: 35271343)
1. The immunology and immunopathology of COVID-19.
Merad M; Blish CA; Sallusto F; Iwasaki A
Science; 2022 Mar; 375(6585):1122-1127. PubMed ID: 35271343
[TBL] [Abstract][Full Text] [Related]
2. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
Boechat JL; Chora I; Morais A; Delgado L
Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
[TBL] [Abstract][Full Text] [Related]
3. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC).
Mohandas S; Jagannathan P; Henrich TJ; Sherif ZA; Bime C; Quinlan E; Portman MA; Gennaro M; Rehman J;
Elife; 2023 May; 12():. PubMed ID: 37233729
[TBL] [Abstract][Full Text] [Related]
4. Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.
Ruenjaiman V; Hirankarn N; Palaga T
Asian Pac J Allergy Immunol; 2021 Jun; 39(2):69-77. PubMed ID: 34174806
[TBL] [Abstract][Full Text] [Related]
5. The role and delicate balance of Host Immunity in Coronavirus Disease-19.
Vyas AK; Varma V; Garg G; Gupta P; Trehanpati N
Iran J Immunol; 2021 Mar; 18(1):1-12. PubMed ID: 33787510
[TBL] [Abstract][Full Text] [Related]
6. Innate and adaptive immune responses against coronavirus.
Hosseini A; Hashemi V; Shomali N; Asghari F; Gharibi T; Akbari M; Gholizadeh S; Jafari A
Biomed Pharmacother; 2020 Dec; 132():110859. PubMed ID: 33120236
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
8. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
[TBL] [Abstract][Full Text] [Related]
9. Immune determinants of COVID-19 disease presentation and severity.
Brodin P
Nat Med; 2021 Jan; 27(1):28-33. PubMed ID: 33442016
[TBL] [Abstract][Full Text] [Related]
10. Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection.
Jung HE; Lee HK
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834939
[TBL] [Abstract][Full Text] [Related]
11. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
12. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions.
Peluso MJ; Donatelli J; Henrich TJ
Transl Res; 2022 Mar; 241():1-12. PubMed ID: 34780969
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
Borges RC; Hohmann MS; Borghi SM
Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
[TBL] [Abstract][Full Text] [Related]
14. A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections.
Alamri A; Fisk D; Upreti D; Kung SKP
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498725
[TBL] [Abstract][Full Text] [Related]
15. Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease.
Todorović-Raković N; Whitfield JR
Cytokine; 2021 Oct; 146():155637. PubMed ID: 34242899
[TBL] [Abstract][Full Text] [Related]
16. Immune profiling of COVID-19: preliminary findings and implications for the pandemic.
Maecker HT
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963016
[TBL] [Abstract][Full Text] [Related]
17. Immunology of SARS-CoV-2 infection in children.
Chou J; Thomas PG; Randolph AG
Nat Immunol; 2022 Feb; 23(2):177-185. PubMed ID: 35105983
[TBL] [Abstract][Full Text] [Related]
18. Adaptive immunity to SARS-CoV-2 and COVID-19.
Sette A; Crotty S
Cell; 2021 Feb; 184(4):861-880. PubMed ID: 33497610
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
Adeniji OS; Giron LB; Purwar M; Zilberstein NF; Kulkarni AJ; Shaikh MW; Balk RA; Moy JN; Forsyth CB; Liu Q; Dweep H; Kossenkov A; Weiner DB; Keshavarzian A; Landay A; Abdel-Mohsen M
mBio; 2021 Apr; 12(2):. PubMed ID: 33879594
[TBL] [Abstract][Full Text] [Related]
20. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review.
Smail SW; Saeed M; Twana Alkasalias ; Khudhur ZO; Younus DA; Rajab MF; Abdulahad WH; Hussain HI; Niaz K; Safdar M
Food Chem Toxicol; 2021 Apr; 150():112087. PubMed ID: 33640537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
